MImAbs will be attending the 66th ASH Annual Meeting from December 7-10, 2024, in San Diego, USA!

Meet our VP of Business Development Nathalie Joly to discover our innovative solutions and explore potential collaborations.

As a CRO specializing in antibody and ADC generation, we ensure seamless preclinical development and efficient transfer to clinical phases with expert support.

#ASH24 #ASH2024 #hematology #Immunotherapy #CancerResearch

#Immunotherapies #oncology #Biotech #MImAbs